{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:34:40Z","timestamp":1791905680824,"version":"4.3.4"},"reference-count":41,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2003,9,22]],"date-time":"2003-09-22T00:00:00Z","timestamp":1064188800000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Eur J of Neuroscience"],"published-print":{"date-parts":[[2003,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Prostaglandins (PGs) are critical mediators of physiologic processes and inflammation. They are produced by two different isoforms of the cyclooxygenase (COX) enzyme, namely COX\u20101 and COX\u20102. In particular COX\u20102 was demonstrated to be crucial for PG\u2010synthesis in inflammation. Recently, inhibition of COX\u20102 was shown to prevent the loss of motor neurons in a model of amyotrophic lateral sclerosis (ALS). Furthermore, spinal COX\u20102 expression was shown to be increased in transgenic mice that produce an ALS\u2013like syndrome. Therefore, we investigated the expression of COX\u20101 and COX\u20102 in the spinal cord of seven human sporadic ALS patients by means of immunohistochemistry. Specimens from seven patients without any neurological disease served as controls. COX\u20102 expression was dramatically increased in the spinal cord of patients with ALS. Its protein was found in motor neurons, interneurons and glial cells. Statistical analysis showed a significantly higher expression of COX\u20102 in ALS for both neurons and glia. In contrast, COX\u20101 expression was predominantly confined to microglia and no apparent difference was detected between controls and ALS. In addition, we studied the concentration of prostaglandin E2 (PG\u2003E<jats:sub>2<\/jats:sub>) as a marker for COX activity in the cerebrospinal fluid of nine patients diagnosed for ALS and compared the results with those from nine patients without motor neuron disease. PG\u2003E<jats:sub>2<\/jats:sub> levels were markedly increased in ALS cases (45.8\u2003\u00b1\u200335.1\u2003pg\/mL) compared to the non\u2010ALS specimens (15.8\u2003\u00b1\u20033.7\u2003pg\/mL). The results of our study corroborate a potential role for COX\u20102 in the pathogenesis of motor neuron death in ALS. Selective COX\u20102 inhibition might therefore offer a new possibility in the treatment of human ALS. However, to determine the exact role of COX\u20102 in human ALS will require further research.<\/jats:p>","DOI":"10.1046\/j.1460-9568.2003.02879.x","type":"journal-article","created":{"date-parts":[[2003,9,22]],"date-time":"2003-09-22T15:51:08Z","timestamp":1064245868000},"page":"1527-1534","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Expression and localization of cyclooxygenase\u20101 and \u20102 in human sporadic amyotrophic lateral sclerosis"],"prefix":"10.1111","volume":"18","author":[{"given":"Christian","family":"Maih\u00f6fner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Probst\u2010Cousin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Neuhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Neund\u00f6rfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Heuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,9,22]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.8.1277"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(96)00604-7"},{"key":"e_1_2_6_5_1","first-page":"96","article-title":"El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases\/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial \u2018Clinical limits of amyotrophic lateral sclerosis\u2019 workshop contributors","volume":"124","author":"Brooks B.R.","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90346-1"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600927"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1006\/exer.2001.0977"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10374"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200011)48:5<792::AID-ANA14>3.0.CO;2-5"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.1998.00273.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/40299"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0953-816x.2001.01828.x"},{"key":"e_1_2_6_14_1","first-page":"139","article-title":"Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration","volume":"9","author":"Ghezzi P.","year":"1998","journal-title":"Eur. Cytokine Netw."},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(98)00214-7"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117620"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12154-2"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(74)90072-0"},{"key":"e_1_2_6_19_1","first-page":"691","article-title":"Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue","volume":"140","author":"Kawamata T.","year":"1992","journal-title":"Am. J. Pathol."},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65199-1"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2001.01420.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5464.335"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgg006"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(00)01302-1"},{"key":"e_1_2_6_25_1","first-page":"2616","article-title":"Expression of cyclooxygenase\u20101 and \u20102 in normal and glaucomatous human eyes","volume":"42","author":"Maihofner C.","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(00)00361-4"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10191"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.301.2.494"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19981001)54:1<1::AID-JNR1>3.0.CO;2-M"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00218-8"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410240314"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0876fje"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2990.2002.00396.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/362059a0"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105313442207"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2000.00075.x"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(97)00228-1"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2990.2001.00354.x"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(73)90193-7"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.38.1.97"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.6.952"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201178"}],"container-title":["European Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1460-9568.2003.02879.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1460-9568.2003.02879.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T18:53:58Z","timestamp":1695754438000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1460-9568.2003.02879.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["10.1046\/j.1460-9568.2003.02879.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1460-9568.2003.02879.x","archive":["Portico"],"relation":{},"ISSN":["0953-816X","1460-9568"],"issn-type":[{"value":"0953-816X","type":"print"},{"value":"1460-9568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]},"assertion":[{"value":"2003-09-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}